Media

February 20, 2025: Hervé Affagard talks Phase 3 results, the regulatory landscape and industry collaborations – Microbiome Times

Date : February 24, 2025

To see the interview click here

February 10, 2025: MaaT Pharma : Pioneering microbiome-driven therapy as new pillar in oncology – Fierce Pharma

March 11, 2025: MaaT Pharma Receives Positive Opinion from EMA Pediatric Committee on the Pediatric Investigation Plan for MaaT013